Original Research

HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial–Mesenchymal Transition

Song H, Tang X, Li X, Wang Y, Deng A, Wang W, Zhang H, Qin H, Wu LQ

Drug Design, Development and Therapy 2020, 14:4291-4302

Published Date: 15 October 2020